Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-21-000443
Filing Date
2021-05-19
Accepted
2021-05-19 10:41:29
Documents
1
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 6375
  Complete submission text file 0001192482-21-000443.txt   8257
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
HALPERN JOHN D (Reporting) CIK: 0001234950 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 21938956

Mailing Address PO BOX 540 PORTSMOUTH NH 03802
Business Address
Halpern Katherine H. (Reporting) CIK: 0001862932 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 21938955